<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zavala VA</submitter><funding>Eunice Kennedy Shriver National Institute of Child Health and Human Development</funding><funding>NICHD NIH HHS</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><pagination>1602-1609</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9662925</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>31(8)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Breast cancer incidence in the United States is lower in Hispanic/Latina (H/L) compared with African American/Black or Non-Hispanic White women. An Indigenous American breast cancer-protective germline variant (rs140068132) has been reported near the estrogen receptor 1 gene. This study tests the association of rs140068132 and other polymorphisms in the 6q25 region with subtype-specific breast cancer risk in H/Ls of high Indigenous American ancestry.&lt;h4>Methods&lt;/h4>Genotypes were obtained for 5,094 Peruvian women with (1,755) and without (3,337) breast cancer. Associations between genotype and overall and subtype-specific risk for the protective variant were tested using logistic regression models and conditional analyses, including other risk-associated polymorphisms in</pubmed_abstract><journal>Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</journal><pubmed_title>Association between Ancestry-Specific 6q25 Variants and Breast Cancer Subtypes in Peruvian Women.</pubmed_title><pmcid>PMC9662925</pmcid><funding_grant_id>R01 HD059835</funding_grant_id><funding_grant_id>R01CA204797</funding_grant_id><funding_grant_id>R01-HD-059835</funding_grant_id><funding_grant_id>R01 CA204797</funding_grant_id><pubmed_authors>Morante Z</pubmed_authors><pubmed_authors>Huntsman S</pubmed_authors><pubmed_authors>Gelaye B</pubmed_authors><pubmed_authors>Castaneda CA</pubmed_authors><pubmed_authors>Liendo-Picoaga R</pubmed_authors><pubmed_authors>Monge C</pubmed_authors><pubmed_authors>Galvez-Nino M</pubmed_authors><pubmed_authors>Navarro-Vasquez J</pubmed_authors><pubmed_authors>Vidaurre T</pubmed_authors><pubmed_authors>Calderon M</pubmed_authors><pubmed_authors>Ziv E</pubmed_authors><pubmed_authors>Cotrina JM</pubmed_authors><pubmed_authors>Godoy L</pubmed_authors><pubmed_authors>Dutil J</pubmed_authors><pubmed_authors>Zabaleta J</pubmed_authors><pubmed_authors>Abugattas JE</pubmed_authors><pubmed_authors>Fuentes HA</pubmed_authors><pubmed_authors>Williams MA</pubmed_authors><pubmed_authors>Sanchez SE</pubmed_authors><pubmed_authors>Zavala VA</pubmed_authors><pubmed_authors>Enriquez-Vera D</pubmed_authors><pubmed_authors>Vasquez J</pubmed_authors><pubmed_authors>Nunez-Marrero A</pubmed_authors><pubmed_authors>Olshen AB</pubmed_authors><pubmed_authors>Neciosup SP</pubmed_authors><pubmed_authors>Fejerman L</pubmed_authors><pubmed_authors>Hu D</pubmed_authors><pubmed_authors>Gomez H</pubmed_authors><pubmed_authors>Casavilca-Zambrano S</pubmed_authors><pubmed_authors>Valencia G</pubmed_authors><pubmed_authors>Hechmer A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Association between Ancestry-Specific 6q25 Variants and Breast Cancer Subtypes in Peruvian Women.</name><description>&lt;h4>Background&lt;/h4>Breast cancer incidence in the United States is lower in Hispanic/Latina (H/L) compared with African American/Black or Non-Hispanic White women. An Indigenous American breast cancer-protective germline variant (rs140068132) has been reported near the estrogen receptor 1 gene. This study tests the association of rs140068132 and other polymorphisms in the 6q25 region with subtype-specific breast cancer risk in H/Ls of high Indigenous American ancestry.&lt;h4>Methods&lt;/h4>Genotypes were obtained for 5,094 Peruvian women with (1,755) and without (3,337) breast cancer. Associations between genotype and overall and subtype-specific risk for the protective variant were tested using logistic regression models and conditional analyses, including other risk-associated polymorphisms in</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2026-05-29T06:39:08.316Z</modification><creation>2025-04-06T00:53:09.353Z</creation></dates><accession>S-EPMC9662925</accession><cross_references><pubmed>35654312</pubmed><doi>10.1158/1055-9965.EPI-22-0069</doi></cross_references></HashMap>